The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Shevchenko Iu.L.

Natsional'nyĭ mediko-khirurgicheskiĭ tsentr im. N.I. Pirogova, Moskva

Stojko Yu.M.

Pirogov National Medical and Surgical Center, Moscow, Russia

Zamyatin M.N.

FGBU «National Medical and Surgical Center named after N.I. Pirogov» Ministry of Health of Russia Russia, Moscow, Russia

Kartasheva E.D.

Nauchnyĭ mediko-khirurgicheskiĭ tsentr im. N.I. Pirogova" Minzdrava RF, Moskva

Standard and new regimens of anticoagulation for pulmonary thromboembolism

Authors:

Shevchenko Iu.L., Stojko Yu.M., Zamyatin M.N., Kartasheva E.D.

More about the authors

Journal: Pirogov Russian Journal of Surgery. 2014;(10): 109‑112

Read: 5605 times

Download PDF (RU)
Contact the author
Table of contents

STANDARD AND NEW REGIMENS OF ANTICOAGULATION FOR PULMONARY THROMBOEMBOLISM
STANDARD AND NEW REGIMENS OF ANTICOAGULATION FOR PULMONARY THROMBOEMBOLISM

To cite this article:

Shevchenko IuL, Stojko YuM, Zamyatin MN, Kartasheva ED. Standard and new regimens of anticoagulation for pulmonary thromboembolism. Pirogov Russian Journal of Surgery. 2014;(10):109‑112. (In Russ.)

Подписка 2026 Хирургия. Журнал им. Н.И. Пирогова (Pirogov Russian Journal of Surgery)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Signs of high embo­lic risk in iliocaval floating thro­mbi. Piro­gov Russian Journal of Surgery. 2025;(3):56-62
Effe­ctiveness of riva­roxaban (Riqulatron) for prevention of venous thro­mboembolic complications in total knee replacement. Piro­gov Russian Journal of Surgery. 2025;(8):55-60
Outpatient Mana­gement of Venous Thro­mboembolism in Acute Phase. Journal of Venous Diso­rders. 2024;(4):328-338
Fibrin mono­mer in diagnosis of cardiovascular diseases. Russian Cardiology Bulletin. 2024;(4-2):113-120
Asplenia — a new cause of thro­mbosis in pregnant women?. Russian Bulletin of Obstetrician-Gynecologist. 2025;(1):71-76
Fatal non-thrombotic pulmonary embo­lism in penis enla­rgement with inje­ctions of hyaluronic acid-based drugs. Fore­nsic Medi­cal Expe­rtise. 2025;(1):59-62
The dyna­mic of concentration of von Willebrand factor concentration in pera­cute and acute periods of cardioembolic stroke during hepa­rin therapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3-2):69-76
Thro­mboembolic complications in the postpartum period. Russian Bulletin of Obstetrician-Gynecologist. 2025;(4):102-107
Ultrasound catheter thro­mbolysis for the treatment of pulmonary embo­lism: the first expe­rience in the Russian Fede­ration. Russian Cardiology Bulletin. 2025;(3):17-24
Abstract:

The article discusses various options of anticoagulant therapy for pulmonary thromboembolism and the main criteria of medication choice including the use of unfractionated heparin, low-molecular-weight heparins, and rivaroxaban. The data presented are based on the own experience and results of international clinical trials.

Keywords:

pulmonary embolism
unfractionated heparin
low-molecular-weight heparins
rivaroxaban

Authors:

Shevchenko Iu.L.

Natsional'nyĭ mediko-khirurgicheskiĭ tsentr im. N.I. Pirogova, Moskva

Stojko Yu.M.

Pirogov National Medical and Surgical Center, Moscow, Russia

Zamyatin M.N.

FGBU «National Medical and Surgical Center named after N.I. Pirogov» Ministry of Health of Russia Russia, Moscow, Russia

Kartasheva E.D.

Nauchnyĭ mediko-khirurgicheskiĭ tsentr im. N.I. Pirogova" Minzdrava RF, Moskva

Close metadata

References:

  1. Rossijskie klinicheskie rekomendatsii po diagnostike, lecheniyu i profilaktike venoznykh tromboehmbolicheskikh oslozhnenij 2010 [Russian clinical recommendations for diagnosis, treatment and prevention of venous thromboembolic events in 2010]. (in Russian)
  2. Agnelli G., Buller H.R., Cohen A. Oral apixaban for the treatment of acute venous thromboembolism. N Engl J Med 2013; 369: 9: 799-808.
  3. Hokusai-VTE Investigators, Büller H.R., Décousus H. Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. N Engl J Med 2013; 369: 15: 1406-1415.
  4. Koertke H., Minami K., Bairaktaris A., Wagner O., Koerfer R. INR self-management following mechanical heart valve replacement. J Thromb Thrombolysis 2000; 9 Suppl 1: 41-45.
  5. Prins M.H., Lensing A.W., Bauersachs R. Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies. Thromb J 2013; 11: 1: 21.
  6. Schulman S., Kearon C., Kakkar A.K. Dabigatran versus warfarin in the treatment of acute venous thromboembolism. N Engl J Med 2009; 361: 24: 2342-2352.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.